Laryngeal airway mask - Airway, laryngeal, single-use Australia - English - Department of Health (Therapeutic Goods Administration)

laryngeal airway mask - airway, laryngeal, single-use

genesis airway innovations pty ltd -

AC MAYHEM 225 INSECTICIDE Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ac mayhem 225 insecticide

axichem pty ltd - methomyl; methanol - liquid concentrate - methomyl carbamate-methylcarbamate active 225.0 g/l; methanol solvent other 593.0 g/l - insecticide

Vitaklenz Herbal Dietary Supplement Australia - English - Department of Health (Therapeutic Goods Administration)

vitaklenz herbal dietary supplement

genesis health products pty ltd - allium sativum,artemisia annua,berberis vulgaris,cucurbita pepo,echinacea purpurea,gentiana macrophylla,handroanthus impetiginosus,juglans nigra,olea europaea,silybum marianum,syzygium aromaticum,thymus vulgaris -

RISPERIDONE SANDOZ risperidone 0.5mg film-coated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

risperidone sandoz risperidone 0.5mg film-coated tablet blister pack

sandoz pty ltd - risperidone, quantity: 0.5 mg - tablet, film coated - excipient ingredients: titanium dioxide; stearic acid; microcrystalline cellulose; iron oxide red; hypromellose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica; lactose monohydrate - treatment of schizophrenia and related psychoses.,short-term treatment of acute mania associated with bipolar i disorder.,treatment (up to 12 weeks) of psychotic symptoms, or persistent agitation or aggression unresponsive to non-pharmacological approaches in patients with moderate to severe dementia of the alzheimer type.,treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with subaverage intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.,treatment of behavioural disorders associated with autism in children and adolescents.

APO-RISPERIDONE risperidone 4mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risperidone risperidone 4mg tablets blister pack

apotex pty ltd - risperidone -

APO-RISPERIDONE risperidone 3mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risperidone risperidone 3mg tablets blister pack

apotex pty ltd - risperidone -

APO-RISPERIDONE risperidone 2mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risperidone risperidone 2mg tablets blister pack

apotex pty ltd - risperidone -

APO-RISPERIDONE risperidone 1mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risperidone risperidone 1mg tablets blister pack

apotex pty ltd - risperidone -

APO-RISPERIDONE risperidone 0.5mg tablets blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-risperidone risperidone 0.5mg tablets blister pack

apotex pty ltd - risperidone -

RISPERIDONE SANDOZ risperidone 4mg film-coated tablet in blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

risperidone sandoz risperidone 4mg film-coated tablet in blister pack

sandoz pty ltd - risperidone, quantity: 4 mg - tablet, film coated - excipient ingredients: magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; indigo carmine aluminium lake; lactose monohydrate; quinoline yellow; pregelatinised maize starch; titanium dioxide; hypromellose; macrogol 4000 - treatment of schizophrenia and related psychoses.,short-term treatment of acute mania associated with bipolar i disorder.,treatment (up to 12 weeks) of psychotic symptoms, or persistent agitation or aggression unresponsive to non-pharmacological approaches in patients with moderate to severe dementia of the alzheimer type.,treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with subaverage intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent.,treatment of behavioural disorders associated with autism in children and adolescents.